Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Bilia in connection with its bond issuance and tender offer
Mandate

Vinge has advised Bilia in connection with its bond issuance and tender offer

June 19, 2023 Banking and Finance

Vinge has advised Bilia AB in connection with its issuance of senior unsecured floating rate bonds in an amount of SEK 800 million (within a framework amount of SEK 1,500 million) and its parallel tender offer in respect of its previously issued bonds due 2023.

DNB Markets, a part of DNB Bank ASA, Sweden Branch and Nordea Bank Abp acted as joint bookrunners and dealer managers in the transaction.

The proceeds from the new bonds are applied towards the financing of the tender offer and for general corporate purposes, and the bonds are intended to listed on the corporate bond list of Nasdaq Stockholm. The bonds have a tenor of five years and were issued with a coupon of STIBOR 3m + 275 basis points.

Vinge’s team consisted of Anders Strid, Lionardo Ojeda and August Ahlin.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025